decisionhealth Newsletters, Answer Books - 2010 Issue 9 (September)
Drugs / Participation in the CAP program suspended
Subscribe or sign in to view the full article.
Article Overview
This article covers a CMS announcement affecting the Competitive Acquisition Program (CAP) for Part B drugs and explains the broader Medicare policy context behind the change. It is relevant for physicians, billing staff, and practice managers who follow Medicare drug purchasing and administration policy, especially those tracking CMS program status, vendor contracting, and payment methodology updates.
Why This Topic Matters
The suspension affects how some practices obtain and bill for Medicare Part B drugs and signals an administrative change in a CMS payment option that had been available under prior policy. Understanding the status of CAP matters for practices that participate in or monitor Medicare drug acquisition arrangements.
What You Will Learn
- Why the CAP program was suspended for 2009
- How CMS described the relationship between CAP and Part B drug purchasing
- The Medicare policy context surrounding the program change
- What the announcement meant for participating practices and vendors
Who Should Read This
- Physicians
- Medical practice managers
- Billing and coding staff
- Healthcare administrators
- Medicare reimbursement specialists
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com